Morphic Holding, Inc. Common Stock

Go to Morphic Holding, Inc. Common Stock Website

$27.97

(%)
Live
Previous Close

$27.97

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$1.4 billion USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Morphic Holding Inc is a biopharmaceutical company applying its insights into integrins to discover and develop a pipeline of oral small-molecule integrin therapeutics. Integrins are a target class with multiple approved injectable blockbuster drugs ...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Morphic (MORF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Related tickers: MORF.

Read Full Article

WALTHAM, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced its participation at investor conferences during the month of March.

Related tickers: MORF.

Read Full Article
Trending Tickers
LASE

XNAS

$1.95
(%)
PACW

XNAS

$7.54
(%)
SMFL

XNAS

$3.20
(%)
SQ

XNYS

$66.84
(%)
MLGO

XNAS

$0.00
(%)